← Browse by Condition
Medical Condition
tricuspid regurgitation
Total Trials
7
Recruiting Now
7
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for tricuspid regurgitation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — tricuspid regurgitation Clinical Trials
How many clinical trials are currently recruiting for tricuspid regurgitation?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for tricuspid regurgitation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for tricuspid regurgitation?
tricuspid regurgitation research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a tricuspid regurgitation clinical trial?
Eligibility criteria for tricuspid regurgitation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06212193
Recruiting
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Enrollment
15 pts
Location
United States, Germa...
Sponsor
Innoventric LTD
NCT06922526
Recruiting
Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes
Enrollment
200 pts
Location
China
Sponsor
Haiyan Wang
NCT02537769
Recruiting
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Enrollment
40 pts
Location
United States
Sponsor
University of Washington
NCT04433065
Recruiting
TTVR Early Feasibility Study
Enrollment
150 pts
Location
United States
Sponsor
Medtronic Cardiovascular
NCT06838611
Recruiting
ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
Enrollment
300 pts
Location
Poland
Sponsor
Medical University of Warsaw
NCT04905017
Recruiting
Trisol System EFS Study
Enrollment
30 pts
Location
United States
Sponsor
Trisol Medical
NCT05797519
Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
Enrollment
120 pts
Location
Australia, Austria, ...
Sponsor
VDyne, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology